$CNC

Centene earnings beat by $0.48, revenue topped estimates

Centene (CNC) reported Q3 EPS of $0.58, beating estimates by $0.48, with revenue at $50.65B, topping consensus of $47.11B. Stock up 11.82% in 3 months, 104.97% in 12 months. InvestingPro rates its financial health as great. 12 positive EPS revisions in 90 days.

Original reporting
Published Oct 27, 2026, 10:11 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 10:25 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CNC
Bullish
high confidence
Mentioned
$CNC
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CNCBullishHigh
01

Why it matters

The earnings surprise may drive short-term buying interest and influence sector peers.

02

Market read

Strong earnings beat could lift Centene and related healthcare stocks.

03

What to watch

Potential impact of Medicaid policy changes on future earnings.

Relevance 8/10Novelty 8/10Timing: after-hours today

Background

Centene is a major managed care company with significant Medicaid enrollment.

Company-level read

Ticker impact

$CNCBullishHigh confidence
Context

Centene reported Q3 EPS of $0.58, beating estimates by $0.48 and revenue of $50.65B versus $47.11B consensus.

Expected impact

likely upward pressure as investors price in the beat.

Evidence & confidence

Both EPS and revenue significantly exceeded expectations, indicating better-than-expected performance.

Market effects

Healthcare services sector may see broader optimism from Centene's beat.

U.S. markets could open higher on earnings momentum.

Limited to U.S. healthcare investors.

Counterpoint

Some analysts may caution that the beat could be one-off and watch for guidance guidance.

Key entities

  • Centene Corporation

    Managed care health insurer.

Related articles

$CNCMedAI 8/10

Centene Corp (CNC) (Q3 2026) Earnings Call Highlights: Raised Guidance and Medicare

Centene Corp (CNC) reported Q3 2026 earnings, raising guidance. Medicaid membership is expected to decline 8-9% YoY by 2026 end, with further attrition in 2027. Medicare Advantage membership may drop YoY in 2027. PDP pretax margin is forecasted to reset lower in 2027, initially at 2-3%. CEO Sarah London addressed market contraction expectations and cost-saving measures during the earnings call.

$CNCMedAI 8/10

What Centene (CNC) Said on Its Q3 Earnings Call

Centene (CNC) reported Q3 earnings, highlighting strong Medicare segment performance with a 93.8% HBR. The company raised its 2026 pre-tax margin forecast for PDP to mid-to-high 3% and expects Medicare Advantage break-even in 2026. Marketplace margins are improving, with a full-year 2026 pre-tax margin expected at the top of the 4.5%-5% range. Centene reduced debt to $15.0B and expects adjusted EPS growth in 2027.

$CNCHighAI 8/10

Centene (CNC) Q3 2026 Earnings Call Transcript

Centene (CNC) reported Q3 2026 earnings, highlighting a Medicaid HBR of 93.6, up 30 basis points from Q2. The company expects full-year Medicaid HBR of 93.5. Medicaid membership was in line with expectations, with a projected 8-9% year-end decline. Medicare Advantage and standalone Part D performed well, with Medicare Advantage on track for 2026 breakeven. Marketplace business is expected to produce a full-year pretax margin at the top of the 4.5% to 5.0% range.

$CNCMed

Centene Corporation Q3 2026 Earnings Call Summary

Centene Corporation reported Q3 2026 earnings, highlighting Medicare Advantage breakeven, Medicaid stability, and Marketplace margin recovery. The company reduced debt to $15.0 billion and expects 2027 adjusted EPS growth. Management plans to exit less profitable areas and optimize costs. Medicaid membership is declining, and Marketplace enrollment may contract in 2027. Non-recurring benefits added $0.50 per share in 2026.

$CNCMed

Centene progresses on profit recovery, drops 6,000 employees

Centene reported Q3 revenue of $50.6B, up 2% YoY, and narrowed losses to $71M. The company raised its 2026 earnings outlook due to Medicare Advantage cost reductions, now expecting to break even in the segment. Centene also announced layoffs and voluntary separations, reducing its workforce by 6,000 employees, which is expected to improve margins in 2027. The company's medical loss ratio was 92.7%, slightly better than expected.